These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24762629)

  • 1. Immunohistochemical monitoring of wound healing in antibiotic treated Buruli ulcer patients.
    Andreoli A; Ruf MT; Sopoh GE; Schmid P; Pluschke G
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2809. PubMed ID: 24762629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue?
    Ruf MT; Sopoh GE; Brun LV; Dossou AD; Barogui YT; Johnson RC; Pluschke G
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1334. PubMed ID: 21980547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.
    Iddrisah FN; Yeboah-Manu D; Nortey PA; Nyarko KM; Anim J; Antara SN; Kenu E; Wurapa F; Afari EA
    Pan Afr Med J; 2016; 25(Suppl 1):13. PubMed ID: 28149438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
    Phillips RO; Robert J; Abass KM; Thompson W; Sarfo FS; Wilson T; Sarpong G; Gateau T; Chauty A; Omollo R; Ochieng Otieno M; Egondi TW; Ampadu EO; Agossadou D; Marion E; Ganlonon L; Wansbrough-Jones M; Grosset J; Macdonald JM; Treadwell T; Saunderson P; Paintsil A; Lehman L; Frimpong M; Sarpong NF; Saizonou R; Tiendrebeogo A; Ohene SA; Stienstra Y; Asiedu KB; van der Werf TS;
    Lancet; 2020 Apr; 395(10232):1259-1267. PubMed ID: 32171422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.
    Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y
    Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin.
    Yeboah-Manu D; Kpeli GS; Ruf MT; Asan-Ampah K; Quenin-Fosu K; Owusu-Mireku E; Paintsil A; Lamptey I; Anku B; Kwakye-Maclean C; Newman M; Pluschke G
    PLoS Negl Trop Dis; 2013; 7(5):e2191. PubMed ID: 23658847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin.
    Schütte D; Um-Boock A; Mensah-Quainoo E; Itin P; Schmid P; Pluschke G
    PLoS Negl Trop Dis; 2007 Oct; 1(1):e2. PubMed ID: 17989779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytosis of Mycobacterium ulcerans in the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesions.
    Schütte D; Umboock A; Pluschke G
    Br J Dermatol; 2009 Feb; 160(2):273-83. PubMed ID: 19016694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?
    Ruf MT; Chauty A; Adeye A; Ardant MF; Koussemou H; Johnson RC; Pluschke G
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1252. PubMed ID: 21829740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load.
    Frimpong M; Agbavor B; Duah MS; Loglo A; Sarpong FN; Boakye-Appiah J; Abass KM; Dongyele M; Amofa G; Tuah W; Frempong M; Amoako YA; Wansbrough-Jones M; Phillips RO
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007689. PubMed ID: 31449522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Outcome of Patients with Buruli Ulcer Disease in Togo.
    Beissner M; Arens N; Wiedemann F; Piten E; Kobara B; Bauer M; Herbinger KH; Badziklou K; Banla Kere A; Löscher T; Nitschke J; Bretzel G
    PLoS Negl Trop Dis; 2015; 9(10):e0004170. PubMed ID: 26474069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing and managing wounds of Buruli ulcer patients at the primary and secondary health care levels in Ghana.
    Addison NO; Pfau S; Koka E; Aboagye SY; Kpeli G; Pluschke G; Yeboah-Manu D; Junghanss T
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005331. PubMed ID: 28245242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.
    Amoussouhoui AS; Sopoh GE; Wadagni AC; Johnson RC; Aoulou P; Agbo IE; Houezo JG; Boyer M; Nichter M
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006291. PubMed ID: 29529087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buruli ulcer: Evaluation of its medical and surgical management at the Allada (Benin) Screening and Treatment Center, 2010-2014.
    Degboe B; Sopoh GE; Alimi M; Koudoukpo C; Akpadjan F; Agbéssi N; Johnson RC; Adégbidi H; Atadokpèdé F
    Med Sante Trop; 2019 Nov; 29(4):402-408. PubMed ID: 31884995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.
    Tuffour J; Owusu-Mireku E; Ruf MT; Aboagye S; Kpeli G; Akuoku V; Pereko J; Paintsil A; Bonney K; Ampofo W; Pluschke G; Yeboah-Manu D
    Am J Trop Med Hyg; 2015 Aug; 93(2):216-23. PubMed ID: 26055745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges associated with the treatment of Buruli ulcer.
    Aboagye SY; Kpeli G; Tuffour J; Yeboah-Manu D
    J Leukoc Biol; 2019 Feb; 105(2):233-242. PubMed ID: 30168876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring.
    Sarfo FS; Le Chevalier F; Aka N; Phillips RO; Amoako Y; Boneca IG; Lenormand P; Dosso M; Wansbrough-Jones M; Veyron-Churlet R; Guenin-Macé L; Demangel C
    PLoS Negl Trop Dis; 2011 Jul; 5(7):e1237. PubMed ID: 21811642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.
    O'Brien DP; McDonald A; Callan P; Robson M; Friedman ND; Hughes A; Holten I; Walton A; Athan E
    PLoS Negl Trop Dis; 2012 Jan; 6(1):e1473. PubMed ID: 22272368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed versus standard assessment for excision surgery in patients with Buruli ulcer in Benin: a randomised controlled trial.
    Wadagni AC; Barogui YT; Johnson RC; Sopoh GE; Affolabi D; van der Werf TS; de Zeeuw J; Kleinnijenhuis J; Stienstra Y
    Lancet Infect Dis; 2018 Jun; 18(6):650-656. PubMed ID: 29605498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.
    Sopoh GE; Dossou AD; Brun LV; Barogui YT; Houézo JG; Affolabi D; Anagonou SY; Johnson RC; Kestens L; Portaels F
    Am J Trop Med Hyg; 2010 Aug; 83(2):307-13. PubMed ID: 20682873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.